EAM Global Investors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,001
Closed -$4.12M 117
2024
Q2
$4.12M Buy
10,001
+1
+0% +$396 0.93% 74
2024
Q1
$4.04M Sell
10,000
-1,533
-13% -$539K 0.93% 70
2023
Q4
$3.54M Sell
11,533
-2,044
-15% -$552K 0.85% 78
2023
Q3
$3.29M Buy
+13,577
New +$3.47M 0.89% 74

Other funds holding MEDP

EAM Global Investors's MEDP Position: Q3 2024 in Review

EAM Global Investors sold out of Medpace (MEDP) in Q3 2024, closing a stake of 10,001 shares — an estimated $4.12M sold.

EAM Global Investors first reported a position in MEDP in Q3 2023 and held it in 4 quarters. The position peaked at $4.12M in Q2 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • EAM Global Investors reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • EAM Global Investors sold 10,001 Medpace shares in Q3 2024, an estimated $4.12M.
  • EAM Global Investors first reported a position in Medpace in Q3 2023 and held it in 4 quarters.
  • EAM Global Investors's Medpace position peaked at $4.12M in Q2 2024.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on EAM Global Investors's 13F filing for Q3 2024, filed 13 Nov 2024.